Imaging CAR-T Synapse as a Quality Control for CAR Engineering
Author:
Xiao Qian,Su Xiaolei
Reference16 articles.
1. June CH, Sadelain M (2018) Chimeric antigen receptor therapy. N Engl J Med 379(1):64–73. https://doi.org/10.1056/NEJMra1706169 2. Weber EW, Maus MV, Mackall CL (2020) The emerging landscape of immune cell therapies. Cell 181(1):46–62. https://doi.org/10.1016/j.cell.2020.03.001 3. Leibman RS, Richardson MW, Ellebrecht CT, Maldini CR, Glover JA, Secreto AJ, Kulikovskaya I, Lacey SF, Akkina SR, Yi Y, Shaheen F, Wang J, Dufendach KA, Holmes MC, Collman RG, Payne AS, Riley JL (2017) Supraphysiologic control over HIV-1 replication mediated by CD8 T cells expressing a re-engineered CD4-based chimeric antigen receptor. PLoS Pathog 13(10):e1006613. https://doi.org/10.1371/journal.ppat.1006613 4. Hale M, Mesojednik T, Romano Ibarra GS, Sahni J, Bernard A, Sommer K, Scharenberg AM, Rawlings DJ, Wagner TA (2017) Engineering HIV-resistant, anti-HIV chimeric antigen receptor T cells. Mol Ther 25(3):570–579. https://doi.org/10.1016/j.ymthe.2016.12.023 5. Ellebrecht CT, Bhoj VG, Nace A, Choi EJ, Mao X, Cho MJ, Di Zenzo G, Lanzavecchia A, Seykora JT, Cotsarelis G, Milone MC, Payne AS (2016) Reengineering chimeric antigen receptor T cells for targeted therapy of autoimmune disease. Science 353(6295):179–184. https://doi.org/10.1126/science.aaf6756
|
|